Skip to main content
Erschienen in: European Radiology 9/2011

01.09.2011 | Breast

Characterization of ductal carcinoma in situ on diffusion weighted breast MRI

verfasst von: Habib Rahbar, Savannah C. Partridge, Peter R. Eby, Wendy B. DeMartini, Robert L. Gutierrez, Sue Peacock, Constance D. Lehman

Erschienen in: European Radiology | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To characterize ductal carcinoma in situ (DCIS) and its subtypes on diffusion-weighted imaging (DWI).

Methods

We retrospectively reviewed 74 pure DCIS lesions in 69 women who underwent DWI at 1.5 T (b = 0 and 600 s/mm2). Each lesion was characterized by qualitative DWI intensity, quantitative DWI lesion-to-normal contrast-to-noise ratio (CNR), and quantitative apparent diffusion coefficient (ADC). The detection rate was calculated with predetermined thresholds for each parameter. The effects of lesion size, grade, morphology, and necrosis were assessed.

Results

Ninety-six percent (71/74) of DCIS lesions demonstrated greater qualitative DWI intensity than normal breast tissue. Quantitatively, DCIS lesions demonstrated on average 56% greater signal than normal tissue (mean CNR = 1.83 ± 2.7) and lower ADC values (1.50 ± 0.28 × 10−3 mm2/s) than normal tissue (2.01 ± 0.37 × 10−3 mm2/s, p < 0.0001). A 91% detection rate was achieved utilizing an ADC threshold (<1.81 × 10−3 mm2/s ). Non-high-grade DCIS exhibited greater qualitative DWI intensity (p = 0.02) and quantitative CNR (p = 0.01) than high-grade DCIS but no difference in ADC (p = 0.40). Lesion size, morphology, and necrosis did not affect qualitative or quantitative DWI parameters of DCIS lesions (p > 0.05).

Conclusions

DCIS lesions have higher DWI signal intensity and lower ADC values than normal breast tissue. DWI warrants further investigation as a potential non-contrast MRI tool for early breast cancer detection.
Literatur
1.
Zurück zum Zitat Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM (2003) Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 10:381–388PubMedCrossRef Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM (2003) Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 10:381–388PubMedCrossRef
2.
Zurück zum Zitat Kuhl CK, Schrading S, Bieling HB et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485–492PubMedCrossRef Kuhl CK, Schrading S, Bieling HB et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485–492PubMedCrossRef
3.
Zurück zum Zitat Lehman CD (2010) Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:150–151CrossRef Lehman CD (2010) Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:150–151CrossRef
4.
Zurück zum Zitat Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L (2005) Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11:382–390PubMedCrossRef Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L (2005) Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11:382–390PubMedCrossRef
5.
Zurück zum Zitat Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD (2007) BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J 13:545–550PubMedCrossRef Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD (2007) BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J 13:545–550PubMedCrossRef
7.
Zurück zum Zitat Koh DM, Padhani AR (2006) Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. Br J Radiol 79:633–635PubMedCrossRef Koh DM, Padhani AR (2006) Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. Br J Radiol 79:633–635PubMedCrossRef
8.
Zurück zum Zitat Yoshikawa MI, Ohsumi S, Sugata S et al (2007) Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med 25:218–223PubMedCrossRef Yoshikawa MI, Ohsumi S, Sugata S et al (2007) Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med 25:218–223PubMedCrossRef
9.
Zurück zum Zitat Woodhams R, Matsunaga K, Kan S et al (2005) ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 4:35–42PubMedCrossRef Woodhams R, Matsunaga K, Kan S et al (2005) ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 4:35–42PubMedCrossRef
10.
Zurück zum Zitat Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH (2007) The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 8:390–396PubMedCrossRef Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH (2007) The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 8:390–396PubMedCrossRef
11.
12.
Zurück zum Zitat Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD (2010) Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 31:562–570PubMedCrossRef Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD (2010) Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 31:562–570PubMedCrossRef
13.
Zurück zum Zitat Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD (2009) Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 193:1716–1722PubMedCrossRef Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD (2009) Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 193:1716–1722PubMedCrossRef
15.
Zurück zum Zitat American College of Radiology (2003) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Reston, VA American College of Radiology (2003) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Reston, VA
16.
Zurück zum Zitat Bogner W, Gruber S, Pinker K et al (2009) Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 253:341–351PubMedCrossRef Bogner W, Gruber S, Pinker K et al (2009) Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 253:341–351PubMedCrossRef
17.
Zurück zum Zitat Silverstein MJ (2003) The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 186:337–343PubMedCrossRef Silverstein MJ (2003) The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 186:337–343PubMedCrossRef
18.
Zurück zum Zitat Esserman LJ, Kumar AS, Herrera AF et al (2006) Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol 24:4603–4610PubMedCrossRef Esserman LJ, Kumar AS, Herrera AF et al (2006) Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol 24:4603–4610PubMedCrossRef
19.
Zurück zum Zitat Jansen SA, Paunesku T, Fan X et al (2009) Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model. Radiology 253:399–406PubMedCrossRef Jansen SA, Paunesku T, Fan X et al (2009) Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model. Radiology 253:399–406PubMedCrossRef
20.
Zurück zum Zitat Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M (2006) Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 24:319–324PubMedCrossRef Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M (2006) Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 24:319–324PubMedCrossRef
21.
Zurück zum Zitat Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C (2007) Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 17:2646–2655PubMedCrossRef Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C (2007) Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 17:2646–2655PubMedCrossRef
22.
Zurück zum Zitat Kuroki Y, Nasu K, Kuroki S et al (2004) Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 3:79–85PubMedCrossRef Kuroki Y, Nasu K, Kuroki S et al (2004) Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 3:79–85PubMedCrossRef
23.
Zurück zum Zitat Woodhams R, Matsunaga K, Iwabuchi K et al (2005) Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 29:644–649PubMedCrossRef Woodhams R, Matsunaga K, Iwabuchi K et al (2005) Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 29:644–649PubMedCrossRef
24.
Zurück zum Zitat Melhem ER, Itoh R, Jones L, Barker PB (2000) Diffusion tensor MR imaging of the brain: effect of diffusion weighting on trace and anisotropy measurements. AJNR Am J Neuroradiol 21:1813–1820PubMed Melhem ER, Itoh R, Jones L, Barker PB (2000) Diffusion tensor MR imaging of the brain: effect of diffusion weighting on trace and anisotropy measurements. AJNR Am J Neuroradiol 21:1813–1820PubMed
25.
Zurück zum Zitat Matsuoka A, Minato M, Harada M et al (2008) Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 26:15–20PubMedCrossRef Matsuoka A, Minato M, Harada M et al (2008) Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 26:15–20PubMedCrossRef
26.
Zurück zum Zitat Dudink J, Larkman DJ, Kapellou O et al (2008) High b-value diffusion tensor imaging of the neonatal brain at 3 T. AJNR Am J Neuroradiol 29:1966–1972PubMedCrossRef Dudink J, Larkman DJ, Kapellou O et al (2008) High b-value diffusion tensor imaging of the neonatal brain at 3 T. AJNR Am J Neuroradiol 29:1966–1972PubMedCrossRef
27.
Zurück zum Zitat Yuen S, Yamada K, Goto M, Nishida K, Takahata A, Nishimura T (2009) Microperfusion-induced elevation of ADC is suppressed after contrast in breast carcinoma. J Magn Reson Imaging 29:1080–1084PubMedCrossRef Yuen S, Yamada K, Goto M, Nishida K, Takahata A, Nishimura T (2009) Microperfusion-induced elevation of ADC is suppressed after contrast in breast carcinoma. J Magn Reson Imaging 29:1080–1084PubMedCrossRef
28.
Zurück zum Zitat Chen G, Jespersen SN, Pedersen M, Pang Q, Horsman MR, Stodkilde-Jorgensen H (2005) Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 23:685–689PubMedCrossRef Chen G, Jespersen SN, Pedersen M, Pang Q, Horsman MR, Stodkilde-Jorgensen H (2005) Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 23:685–689PubMedCrossRef
Metadaten
Titel
Characterization of ductal carcinoma in situ on diffusion weighted breast MRI
verfasst von
Habib Rahbar
Savannah C. Partridge
Peter R. Eby
Wendy B. DeMartini
Robert L. Gutierrez
Sue Peacock
Constance D. Lehman
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 9/2011
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-011-2140-4

Weitere Artikel der Ausgabe 9/2011

European Radiology 9/2011 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.